Impact of Magnetic Stimulation on Pain in Endometriosis Patients

Kantonsspital Winterthur KSW

Status

Not yet enrolling

Conditions

Endometriosis

Treatments

Device: Magnetic stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT07265687

2025-D0011 (Other Identifier)

Tesla-Endom

Details and patient eligibility

About

Many women with endometriosis still experience pain despite surgical and medical treatment. Over-the-counter painkillers are usually helpful in alleviating this pain. But for some patients, these medications eventually stop working. Pain then dominates their daily life. In this study, we are investigating the effects of magnetic stimulation using the "Tesla chair" and whether it can alleviate their pain

Full description

Patients who are diagnosed with CPP and hypertonic pelvic floor as assessed in gynaecological exam will be asked to participate. Before start of the Tesla chair treatment VAS Score by PPAF will be assessed. After 6 treatments (after 3 weeks an intermediate doctor's consultation will rule out aggravation of CPP by treatment and if possible the next cycle of 6 treatments will be scheduled. After completion of 12 treatments the VAS Score will be reassessed and treatments' success evaluated in a doctor's consultation. We plan to re-evaluate sustaining success after 3 months after treatments completion

Enrollment

30 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient has been informed about study
Age ≥ 18 years
Premenopausal
histologically or laparoscopically or MRI confirmed endometriosis
CPP (cyclical pelvic pain VAS ≥ 5)
Pelvic floor hypertonicity
Written informed consent
sufficient German speaking
Current endocrine therapy for >= 3 months

Exclusion criteria

Contraindications according manufactureres manual Tesla Chair
Pregnancy or desire to become pregnant within the next 8 weeks
Pelvic organ prolapses
Genital infections
Menstruation
active malignancy, Malignant tumors
Severe neurological diseases
Cardiac arrhythmia
Active internal medical devices e.g. cardiac pacemakers, medication, pumps etc.
Ferromagnetic implants at or near the site of stimulation
Recent surgery at the site of stimulation
Thrombosis or thrombophlebitis
Epilepsy or suspected epilepsy
Acute stages of kidney stones
Gastrointestinal and internal disease at the site of stimulation
Known or suspected non-compliance, drug or alcohol abuse
Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject
Participation in another investigation with an investigational drug or another MD within the 30 days preceding and during the present investigation
Previous enrolment into the current investigation
Enrolment of the Sponsor or PI, their family members, employees and other dependent persons
No endocrine therapy or use of endocrine therapy for < 3 months
active inflammatory diseases